Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value ($000): $404,096 (100.0% shares, 0.0% debt)

Holdings (7)

MDXG MIMEDX GROUP, INC. 61.2%

Value ($000) $247,272 Shares 28,195,249 Est. Cost $7.32 Unrealized 0.0%

BVS BIOVENTUS 17.0%

Value ($000) $68,622 Shares 13,021,324 Est. Cost $13.37 Unrealized -70.4%

EYPT EYEPOINT PHARMACEUTICALS INC 13.4%

Value ($000) $54,026 Shares 2,337,786 Est. Cost $4.68 Unrealized +138.8%

TELA TELA BIO, INC. 6.7%

Value ($000) $27,213 Shares 4,110,709 Est. Cost $11.82 Unrealized -51.1%

— REVANCE THERAPEUTICS INC 1.0%

Value ($000) $4,018 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 0.4%

Value ($000) $1,659 Shares 1,105,941 Est. Cost $2.95 Unrealized -38.7%

— VENUS CONCEPT, INC. 0.3%

Value ($000) $1,285 Shares 1,089,190 Est. Cost $2.12 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	28,195,249	$247,272	61.2%	$7.32	0.0%	COM	602496101
BVS	BIOVENTUS	13,021,324	$68,622	17.0%	$13.37	-70.4%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	2,337,786	$54,026	13.4%	$4.68	+138.8%	COM NEW	30233G209
TELA	TELA BIO, INC.	4,110,709	$27,213	6.7%	$11.82	-51.1%	COM	872381108
—	REVANCE THERAPEUTICS INC	457,085	$4,018	1.0%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$1,659	0.4%	$2.95	-38.7%	COM NEW	58468P206
—	VENUS CONCEPT, INC.	1,089,190	$1,285	0.3%	$2.12	—	COM	92332W105